C. Pivot

721 total citations
49 papers, 404 citations indexed

About

C. Pivot is a scholar working on Geriatrics and Gerontology, Occupational Therapy and Pharmacology. According to data from OpenAlex, C. Pivot has authored 49 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Geriatrics and Gerontology, 8 papers in Occupational Therapy and 7 papers in Pharmacology. Recurrent topics in C. Pivot's work include Pharmaceutical Practices and Patient Outcomes (10 papers), Safe Handling of Antineoplastic Drugs (8 papers) and Patient Safety and Medication Errors (6 papers). C. Pivot is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (10 papers), Safe Handling of Antineoplastic Drugs (8 papers) and Patient Safety and Medication Errors (6 papers). C. Pivot collaborates with scholars based in France, India and United States. C. Pivot's co-authors include Fabrice Pirot, M. Perraud, Julien Jean, Yves Perrodin, Fabrice Pirot, G. Galy, Évelyne Decullier, Sophie Dupuis‐Girod, Fréderic Faure and Jean‐Yves Scoazec and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Journal of Environmental Management.

In The Last Decade

C. Pivot

45 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Pivot France 11 69 61 53 47 43 49 404
Stéphanie Genay France 12 24 0.3× 82 1.3× 10 0.2× 34 0.7× 8 0.2× 40 401
Alan E. Polack Australia 13 13 0.2× 81 1.3× 57 1.1× 55 1.2× 157 3.7× 29 504
Jean Vigneron France 9 6 0.1× 117 1.9× 29 0.5× 133 2.8× 14 0.3× 51 405
Nicolas Simon France 14 10 0.1× 119 2.0× 9 0.2× 154 3.3× 15 0.3× 71 604
M.C. Allwood United Kingdom 17 8 0.1× 218 3.6× 18 0.3× 61 1.3× 45 1.0× 43 788
Mohammed N. Al-Arifi Saudi Arabia 13 18 0.3× 21 0.3× 87 1.6× 4 0.1× 11 0.3× 30 433
D. Gayle DeBord United States 13 24 0.3× 201 3.3× 13 0.2× 302 6.4× 4 0.1× 23 790
Prashant Sakharkar United States 11 44 0.6× 63 1.0× 93 1.8× 7 0.1× 3 0.1× 32 415
Alan H. Lau United States 16 15 0.2× 131 2.1× 30 0.6× 2 0.0× 17 0.4× 56 895
E Mutch United Kingdom 13 18 0.3× 32 0.5× 7 0.1× 3 0.1× 7 0.2× 19 474

Countries citing papers authored by C. Pivot

Since Specialization
Citations

This map shows the geographic impact of C. Pivot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pivot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pivot more than expected).

Fields of papers citing papers by C. Pivot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Pivot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pivot. The network helps show where C. Pivot may publish in the future.

Co-authorship network of co-authors of C. Pivot

This figure shows the co-authorship network connecting the top 25 collaborators of C. Pivot. A scholar is included among the top collaborators of C. Pivot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Pivot. C. Pivot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pivot, C., et al.. (2019). Analyse des risques a priori en unité de rétrocession hospitalière : focus sur le processus de dispensation. Annales Pharmaceutiques Françaises. 78(1). 12–20. 5 indexed citations
2.
Pivot, C., et al.. (2018). Production and stability study of a hospital parenteral nutrition solution for neonates. Journal of Pharmaceutical Analysis. 9(2). 83–90. 10 indexed citations
3.
Galy, G., et al.. (2015). Evaluation of Safe Infusion Devices for Antineoplastic Administration. Journal of Infusion Nursing. 38(Supplement 6S). S29–S35. 4 indexed citations
4.
Haftek, Marek, et al.. (2015). New easy handling and sampling device for bioavailability screening of topical formulations. European Journal of Dermatology. 25(S1). 23–29. 8 indexed citations
5.
Janoly-Duménil, A., et al.. (2015). Interventions des pharmaciens sur les prescriptions ambulatoires dans le cadre de l’activité de rétrocession d’un centre hospitalier universitaire. Annales Pharmaceutiques Françaises. 73(4). 297–306. 10 indexed citations
6.
Colombel, Marc, et al.. (2014). Bladder tissue permeability and transport modelling of intravesical alum, lidocaine hydrochloride, methylprednisolone hemisuccinate and mitomycin C. International Journal of Pharmaceutics. 464(1-2). 91–103. 9 indexed citations
7.
8.
9.
Baudouin, Anne, et al.. (2014). Avantages et spécificités des préparations hospitalières de nutrition parentérale en néonatalogie. Annales Pharmaceutiques Françaises. 73(2). 150–159. 1 indexed citations
10.
Dhelens, C., et al.. (2014). Implication pharmaceutique dans le cadre d’essais cliniques institutionnels : évaluation de la qualité des opérations de mise sous forme pharmaceutique. Annales Pharmaceutiques Françaises. 73(3). 197–214. 3 indexed citations
11.
Pivot, C., et al.. (2013). Pharmaceutical and safety considerations of tablet crushing in patients undergoing enteral intubation. International Journal of Pharmaceutics. 443(1-2). 146–153. 28 indexed citations
12.
Jean, Julien, et al.. (2012). Identification and prioritization of bioaccumulable pharmaceutical substances discharged in hospital effluents. Journal of Environmental Management. 103. 113–121. 79 indexed citations
13.
Michallet, Mauricette, Mohamad Sobh, Stéphane Morisset, et al.. (2012). Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. Cancer. 119(1). 107–114. 13 indexed citations
14.
Galy, G., et al.. (2012). Evaluation of Safe Infusion Devices for Antineoplastic Administration. Journal of Infusion Nursing. 35(5). 321–327. 5 indexed citations
15.
Armoiry, Xavier, et al.. (2010). Contrat de bon usage : mise en œuvre opérationnelle des référentiels de bon usage aux hospices civils de Lyon. Annales Pharmaceutiques Françaises. 68(3). 148–156. 3 indexed citations
16.
Uhart, M., Fabrice Pirot, C. Burillon, et al.. (2010). Assessment of sodium hyaluronate gel as vehicle for intracameral delivery of cefuroxime in endophthalmitis prophylaxis. International Journal of Pharmaceutics. 398(1-2). 14–20. 9 indexed citations
17.
18.
Favier, Bertrand, F. Rull, C. Pivot, et al.. (2001). Surface and human contamination with 5-fluorouracil in six hospital pharmacies. Journal de Pharmacie Clinique. 20(3). 6 indexed citations
19.
Favier, Bertrand, et al.. (2001). Evaluation de la contamination de l'environnement matériel et humain par le 5-fluoro-uracile lors de la manipulation en unités de reconstitution des chimiothérapies. Journal de Pharmacie Clinique. 20(3). 157–162. 6 indexed citations
20.
Maire, Pascal, Xavier Barbaut, J.M. Vergnaud, et al.. (1994). Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy. International Journal of Bio-Medical Computing. 36(1-2). 77–85. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie Genay Breakdown of academic impact, for papers by Alan E. Polack Breakdown of academic impact, for papers by Jean Vigneron Breakdown of academic impact, for papers by Nicolas Simon Breakdown of academic impact, for papers by M.C. Allwood Breakdown of academic impact, for papers by Mohammed N. Al-Arifi Breakdown of academic impact, for papers by D. Gayle DeBord Breakdown of academic impact, for papers by Prashant Sakharkar Breakdown of academic impact, for papers by Alan H. Lau Breakdown of academic impact, for papers by E Mutch
Rankless by CCL
2026